Welcome!
dividend
Investing strategies
Equity income: A sensible choice amid economic resilience and higher-for-longer rates
A dynamic dividend strategy can diversify across sectors and countries and is style-agnostic regarding value or growth
March 20, 2024
Banking & finance
DBS has sufficient capital for growth and dividends, with no stress in CRE book
DBS has sufficient capital for growth, maintaining dividends of 54 cents per quarter, and special dividend in the future
February 14, 2024
Investing strategies
The compelling case for dividend investing in Asia — whatever the economic backdrop
Dividends are an important part of equity investing in Asia.
February 22, 2023
Investing strategies
Recession comes: How can a dividend strategy help mitigate the investment risk?
Year on year, we've seen the resilience of dividend payments by global companies, plus rowth in the size of these dividend payouts
October 06, 2022
Investing strategies
Beware the yield trap
Dividends and distribution yields should not be confused.
August 04, 2022
Company in the news
Hiap Hoe to propose final dividend of 0.5 cent per share at next company AGM
The company’s statement comes in response to a shareholder’s query before the AGM.
April 28, 2021
Gold
CNMC Goldmine to strike while the iron is hot
SINGAPORE (Nov 25): On the whole, Catalist-listed CNMC Goldmine Holdings, which operates three mines in Malaysia, has benefited from higher gold prices.
November 22, 2019
Broker's Calls
Yangzijiang may be the only O&M stock to deliver stronger q-o-q results this season: CGS-CIMB
SINGAPORE (July 13): CGS-CIMB Securities is maintaining its sector “overweight” on Singapore’s offshore & marine (O&M) industry with expectations of Yangzijiang Shipbuilding to deliver stronger q-o-q earnings on stronger shipbuilding margins.
July 13, 2018
Broker's Calls
Disposal gains could lead to higher-than-expected 4Q earnings for SATS
SINGAPORE (May 17): UOB Kay Hian is estimating SATS will post a 25% y-o-y increase in headline net profit when the airline gateway services and food solutions provider reports its FY17 earnings this Friday, versus the street’s implied estimate of 4.3% g
May 17, 2017
Broker's Calls
Despite lacklusture topline, this S-chip’s FY16 performance shone in more ways than one
SINGAPORE (April 5): CIMB Research is maintaining its “add” recommendation on Tianjin Zhongxin Pharmaceutical Group with an unchanged target price of US$1.30 ($1.82) as it continues to like the S-share as a “cheap proxy for China’s growing pharmac
April 05, 2017